Xenon Pharmaceuticals (XENE) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts XENE Hot Sheet
Join SI Premium – FREE
Xenon Pharmaceuticals (NASDAQ: XENE) reported Q2 EPS of ($0.07), $0.09 better than the analyst estimate of ($0.16).
For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xenon Pharmaceuticals (XENE) PT Lowered to $60 at Needham
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Xenon to Present at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
